MARC Record from harvard_bibliographic_metadata

LEADER: 01893cam a2200361 a 4500
001 012846099-7
005 20111209191757.0
008 110330s2011 mnuac 001 0 eng d
010 $a 2011924524
020 $a9780979016431
020 $a0979016436
035 0 $aocn711043539
040 $aBTCTA$beng$cBTCTA$dPFM
060 00 $a2012 H-251
060 10 $aQV 150
060 4 $aQV 150$bC27538 2011
090 $aRM345$b.F75 2011
245 00 $aCardiovascular pharmacotherapeutics /$cedited by William H. Frishman, Domenic A. Sica.
250 $a3rd ed.
260 $aMinneapolis, Minn. :$bCardiotext,$cc2011.
300 $axix, 775 p. :$bill., port. ;$c29 cm.
500 $aIncludes index.
500 $aBibliographical references available online in the form of downloadable PDFs at www.cvpct3.com --P. xvi.
520 $aA critically acclaimed classic reference now in its third edition, this provides current information regarding the contemporary use of all available cardiovascular medications for adults and children. Strongly emphasizing the scientific rationale behind the use of such therapies in cardiac disease, it discusses new drugs and novel compounds that are under development and may emerge as the cardiac therapies of the future. This edition also addresses special considerations for drug therapy use in the elderly, during pregnancy, and in those with hepatic or renal disease. A generous assortment of tables, figures, and appendices guides readers in their investigations of each drug group and various disease states.
650 22 $aCardiovascular System$xdrug effects.
650 22 $aCardiovascular Diseases$xdrug therapy.
650 12 $aCardiovascular Agents$xpharmacology.
650 0 $aCardiovascular agents.
650 12 $aCardiovascular Agents.
700 1 $aFrishman, William H.,$d1946-
700 1 $aSica, Domenic A.
988 $a20110804
906 $0OCLC